跳至主要内容
临床试验/NL-OMON51200
NL-OMON51200尚未招募不适用

Quantitative mpMRI to predict metastatic potential of prostate cancer - QmpMRI

Radboud Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Histologically proven primary cancer of the prostate, based on prostate
  • biopsy-core analysis.
  • - Patient is scheduled and fit for PSMA-PET/CT
  • - Age*50 years. Ability to give voluntary written informed consent to
  • participate in this study.

排除标准

  • - Contraindication for MRI-scanning, i.e. claustrophobia, intracranial metal
  • clips, metallic bodies in the eye, implanted electric and electronic devices
  • not eligible for MRI (pacemakers, insulin pumps, cochlear implants,
  • neurostimulators).
  • - Prior prostate cancer treatment.
  • - Prior pelvic surgery, associated with pelvic lymphadenopathy
  • - Presence of any medical condition that in the opinion of the
  • investigator/treating physician will affect patients* clinical status by
  • participating in this trial.
  • - Inability to lie still for 45 minutes or comply with imaging.
  • - The patient is already enrolled in one or more concurrent studies, which
  • could confound the results of this study, according to the investigators.

研究者

相似试验